Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$337K Sell
1,146
-1,270
-53% -$350K 0.03% 464
2022
Q3
$554K Sell
2,416
-130
-5% -$32.6K 0.07% 400
2022
Q2
$554K Sell
2,546
-2,470
-49% -$561K 0.06% 433
2022
Q1
$1.34M Sell
5,016
-151
-3% -$37.1K 0.13% 272
2021
Q4
$1.37M Hold
5,167
0.13% 271
2021
Q3
$1.47M Sell
5,167
-53
-1% -$15.1K 0.14% 241
2021
Q2
$1.43M Buy
5,220
+24
+0.5% +$6.52K 0.13% 242
2021
Q1
$1.35M Buy
5,196
+1,054
+25% +$282K 0.14% 244
2020
Q4
$1.06M Sell
4,142
-5,610
-58% -$1.39M 0.11% 301
2020
Q3
$2.31M Buy
9,752
+1,773
+22% +$373K 0.25% 96
2020
Q2
$1.55M Buy
7,979
+3,669
+85% +$701K 0.18% 176
2020
Q1
$251K Buy
4,310
+3,284
+320% +$600K 0.03% 477
2019
Q4
$176K Buy
+1,026
New +$171K 0.02% 559

Other funds holding PODD

Seeyond's PODD Position: Q4 2022 in Review

Seeyond reduced its Insulet (PODD) stake by 53% in Q4 2022, selling an estimated $350K and leaving 1,146 shares worth $337K. The position accounts for 0.03% of the portfolio, ranked #464.

Seeyond first reported a position in PODD in Q4 2019 and has held it in 13 quarters since. The position peaked at $2.31M in Q3 2020. 525 funds tracked by Wall St. Rank hold PODD as of Q4 2022.

  • Seeyond held 1,146 shares of Insulet worth $337K as of Q4 2022.
  • Seeyond sold 1,270 Insulet shares in Q4 2022, an estimated $350K.
  • Insulet made up 0.03% of Seeyond's portfolio in Q4 2022, its #464 holding.
  • Seeyond first reported a position in Insulet in Q4 2019 and has held it in 13 quarters since.
  • Seeyond's Insulet position peaked at $2.31M in Q3 2020.
  • 525 funds tracked by Wall St. Rank held Insulet as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.